Ping Liu

physician
Zhengzhou People's Hospital
Zhengzhou, Henan, China (People's Republic)

Presentation(s):

• OC 24.5 - A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of a PEGylated-Recombinant Human Coagulation Factor VIII-Fc Fusion Protein in Patients With Severe Hemophilia A

  Sunday, June 25, 2023
  15:45 – 16:00 ET